Plasma Urotensin in Human Systolic Heart Failure
- 3 December 2002
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (23) , 2877-2880
- https://doi.org/10.1161/01.cir.0000044388.19119.02
Abstract
Background— Human urotensin II (UTN) has potent vasoactive and cardiostimulatory effects, acting on the G protein–linked receptor GPR14. Myocardial UTN expression is upregulated in heart failure, a...Keywords
This publication has 15 references indexed in Scilit:
- Congestive heart failure and expression of myocardial urotensin IIThe Lancet, 2002
- Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferationJournal Of Hypertension, 2001
- Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal ratsFEBS Letters, 2001
- Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteriesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2001
- Cardiostimulant effects of urotensin‐II in human heart in vitroBritish Journal of Pharmacology, 2001
- Human urotensin‐II is an endothelium‐dependent vasodilator in rat small arteriesBritish Journal of Pharmacology, 2000
- Human Urotensin-II is a Potent Vasoactive PeptideJournal of Cardiovascular Pharmacology, 2000
- Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14Nature, 1999
- Development of a novel, N-Terminal-proBNP (NT-proBNP) assay with a low detection limitScandinavian Journal of Clinical and Laboratory Investigation, 1999
- Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairmentClinical Endocrinology, 1997